LATE BREAKING ABSTRACT: Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD...

Date 27 September 2015
Event European Cancer Congress 2015
Session Immunotherapy in Cancer I
Topics Cancer Immunology and Immunotherapy
Presenter Besse, B.